CN105418488A - Preparation method of donepezil hydrochloride - Google Patents

Preparation method of donepezil hydrochloride Download PDF

Info

Publication number
CN105418488A
CN105418488A CN201511030894.XA CN201511030894A CN105418488A CN 105418488 A CN105418488 A CN 105418488A CN 201511030894 A CN201511030894 A CN 201511030894A CN 105418488 A CN105418488 A CN 105418488A
Authority
CN
China
Prior art keywords
preparation
ionic liquid
reaction
compound
acidic ionic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201511030894.XA
Other languages
Chinese (zh)
Other versions
CN105418488B (en
Inventor
孙松
刘桂军
李文婷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong Luoxin Pharmaceutical Group Co Ltd
Original Assignee
Shandong Luoxin Pharmaceutical Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong Luoxin Pharmaceutical Group Co Ltd filed Critical Shandong Luoxin Pharmaceutical Group Co Ltd
Priority to CN201511030894.XA priority Critical patent/CN105418488B/en
Publication of CN105418488A publication Critical patent/CN105418488A/en
Application granted granted Critical
Publication of CN105418488B publication Critical patent/CN105418488B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

The invention discloses a preparation method of donepezil hydrochloride. The preparation method comprises the steps that 3-chlorine-1-(3, 4-dimethoxy phenyl) propane-1-ketone (II) is made to react with N-benzyl-4-formyl-piperidine (III) under the condition of a lewis acid ionic liquid catalyst, and 1-benzyl-4-(5, 6dimethoxy-1-indanone-2-methylene)-piperidine (IV) is obtained through a one-pot method, and then the donepezil hydrochloride (I) is obtained through reduction and salt formation. The preparation method of the donepezil hydrochloride has the advantages of being simple in process, low in production cost, environmentally friendly and suitable for industrialized production.

Description

A kind of preparation method of E 2020
Technical field
The invention belongs to technical field of medicine synthesis, particularly a kind of preparation method of E 2020.
Background technology
E 2020 is the exploitation of Japanese Wei Cai company, the acetylcholinesterase depressant for the treatment of Alzheimer's dementia (AD).Have high selectivity, dosage is little, long half time, and untoward reaction is little, without advantages such as hepatotoxicities.Chemical name is: 1-benzyl-4-[(5,6-dimetlioxyindan ketone-2-base) methyl] piperidine hydrochlorate.E 2020 (I) structural formula is as follows:
Its existing operational path synthesis is as follows:
1) synthetic route of CN201010600277.X report, with N-benzyl-4-piperidine carboxylic acid for compound 4 prepared by raw material, compound 4 and compound 5 carry out Aldol condensation reaction under basic conditions, and then obtain E 2020 through reduction, salify, and synthetic route is as follows:
This route shortcoming is starting raw material 5,6-dimethoxy-1-indone need synthesize (with 3 through polystep reaction, 4-dimethylbenzaldehyde is starting raw material, obtain through condensation, reduction, ring closure reaction), or marketable material is expensive, and using highly basic NaH to carry out Aldol condensation reaction, aftertreatment bothers, and is unfavorable for suitability for industrialized production.
2) CN100436416 reports that synthetic route is as follows:
Take diethyl malonate as starting raw material, by condensation, reduction, replacement, finally close the obtained E 2020s of five step reactions such as ring decarboxylation, step is more, and yield is low.
Summary of the invention
The invention provides that a kind of E 2020 technique is simple, production cost is low, the preparation method of environmental protection.
The preparation method of a kind of E 2020 provided by the invention, comprises the following steps:
A, compound ii and compound III are reacted under Lewis acidic ionic liquid catalysts conditions, and one kettle way obtains compounds Ⅳ;
By adding in reactor by reactant under Lewis acidic ionic liquid catalyst action in the present invention, carry out condensation and pay gram alkylation one kettle way obtaining, reaction formula is as follows:
B, compounds Ⅳ obtain chemical compounds I through reduction, salify.
Lewis acidic ionic liquid catalyzer of the present invention is obtained by reacting by quaternary amine and Lewis acid, and wherein, quaternary amine is triethylamine hydrochloride, chlorination N-alkyl pyridine or chlorination 1,3-dialkylimidazolium; Lewis acid is aluminum trichloride (anhydrous), FERRIC CHLORIDE ANHYDROUS or Zinc Chloride Anhydrous.
Lewis acidic ionic liquid catalyst synthesis step of the present invention is: under nitrogen protection; 1:1 ~ 1:6 is by quaternary amine and Lewis acid batch mixing in molar ratio; control temperature 40 ~ 100 DEG C in mixing process, and keep reaction 3 hours in 40 ~ 100 DEG C, obtain Lewis acidic ionic liquid.
In the compounds of this invention II, compound III and ionic liquid, between Lewis acid, mol ratio is 1:1 ~ 1.1:2 ~ 3.
Aldol condensation reaction temperature of the present invention is 40 ~ 60 DEG C, preferably 55 ~ 60 DEG C, and the time is 4 ~ 5 hours, preferably 4.5 ~ 5 hours; Described pair gram of alkylating temperature of reaction is 145 ~ 175 DEG C, preferably 165 ~ 175 DEG C, and the reaction times is 5 ~ 6 hours, preferably 5.5 ~ 6 hours;
Beneficial effect of the present invention is as follows:
The chloro-1-(3 of 1.3-, 4-Dimethoxyphenyl) propane-1-ketone (II) starting raw material is easy to get, and directly use 5 than (patent CN201010600277.X) in regular course, 6-dimethoxy-1-indone participates in the more economical material benefit of Aldol condensation reaction, and this preparation method, by condensation, pair gram alkylated reaction two step one pot reaction, makes processing step shorten, operation is easy, decrease the purifying of intermediate, dry, reduce production cost.
2. use ionic-liquid catalyst as reaction medium and catalyzer, there is reaction conditions gentleness, product is easily separated with catalyst system, environmental friendliness, yield are high, feature that catalyzer can be recycled.
3. the shortcomings such as Aldol condensation reaction uses Lewis acidic ionic liquid to carry out catalysis, changes traditional inorganic acids or mineral alkali side reaction is many, and corrodibility is strong, and in reaction the complicated and contaminate environment of aftertreatment is serious.
4. carry out catalytic hydrogenation reaction with non-hydrogen Virahol, formic acid for hydrogen source, compared with using the hydrogenation process of hydrogen, have that security is high, reaction conditions is gentle, equipment requirements is low and selectivity advantages of higher.
Embodiment
Below by specific embodiment, summary of the invention of the present invention is described in further detail, but does not therefore limit content of the present invention.
Embodiment 1
Using chlorination 1-ethyl-3-methylimidazole-aluminum chloride as ionic liquid catalyst systems, concrete steps are as follows:
[Emim] Cl-AlCl 3preparation (Emim=1-ethyl-3-methylimidazole)
Device agitator on reactor; add 26.67g (0.2mol) aluminum trichloride (anhydrous) under nitrogen protection; add 29.3g (0.2mol) chlorination 1-ethyl 3-Methylimidazole in batches; remain on about 50 DEG C after adding to stir 3 hours; guarantee to react completely, [Emim] Cl-AlCl of obtained clear, yellowish 3ionic liquid.
The preparation of 1-benzyl-4-(5,6 dimethoxy-1-indone-2-methylene radical)-piperidines (IV)
Under nitrogen protection; the chloro-1-of 3-(3,4-Dimethoxyphenyl) propane-1-ketone (II) 22.9g (0.1mol), N-benzyl-4-piperidyl formaldehgde (III) 20.3g (0.1mol), [Emim] Cl-AlCl is added successively in there-necked flask 3(0.2mol), control temperature 40 ~ 45 DEG C is also held time 4.5 hours, be warmed up to 145 ~ 155 DEG C and maintain reaction 5.5 hours, TLC monitors reaction end, after reaction terminates, be down to room temperature, product and ionic liquid AUTOMATIC ZONING, product layer is poured in 5% hydrochloric acid frozen water, and suction filtration obtains crude product, by re-crystallizing in ethyl acetate, obtain 1-benzyl-4-(5,6 dimethoxy-1-indone-2-methylene radical)-piperidines (IV) 32.5g, yield 86%, purity 99.6%, ionic liquid layer dewater Posterior circle use.
The preparation method referenced patent CN201010600277.X of N-benzyl-4-piperidyl formaldehgde (III).
Embodiment 2
The preparation of ionic liquid
Device agitator on reactor, adds 27.3g (0.2mol) anhydrous ZnCl under nitrogen protection 2, add 34.9g (0.2mol) chlorination 1-butyl-3-Methylimidazole ([Bmim] Cl) in batches.Remain on about 40 DEG C after adding imidazole salts to stir 3 hours, guarantee to react completely, obtained water white [Bmim] Cl-ZnCl 2ionic liquid.
The preparation of 1-benzyl-4-(5,6 dimethoxy-1-indone-2-methylene radical)-piperidines (IV)
Under nitrogen protection; the chloro-1-of 3-(3,4-Dimethoxyphenyl) propane-1-ketone (II) 22.9g (0.1mol), N-benzyl-4-piperidyl formaldehgde (III) 20.3g (0.1mol), [Bmim] Cl-ZnCl is added successively in there-necked flask 2(0.2mol), control temperature 45 ~ 50 DEG C is also held time 4 hours, be warmed up to 155 ~ 165 DEG C and maintain reaction 5 hours, TLC monitors reaction end, after reaction terminates, be down to room temperature, product and ionic liquid AUTOMATIC ZONING, product layer is separated and pours in 5% hydrochloric acid frozen water, and suction filtration obtains crude product, by re-crystallizing in ethyl acetate, obtain 1-benzyl-4-(5,6 dimethoxy-1-indone-2-methylene radical)-piperidines (IV) 31.0g, yield 82%, purity 99.6%, ionic liquid layer dewater Posterior circle use.
Embodiment 3
The preparation of ionic liquid
Device agitator on reactor, adds 40.0g (0.3mol) anhydrous AlCl under nitrogen protection 3, add 27.5g (0.2mol) triethylamine hydrochloride ([Et in batches 3nH] Cl).Remain on about 60 DEG C after adding triethylamine hydrochloride to stir 3 hours, guarantee to react completely, obtained transparent [Et 3nH] Cl-AlCl 3ionic liquid.
The preparation of 1-benzyl-4-(5,6 dimethoxy-1-indone-2-methylene radical)-piperidines (IV)
Under nitrogen protection; the chloro-1-of 3-(3,4-Dimethoxyphenyl) propane-1-ketone (II) 22.9g (0.10mol), N-benzyl-4-piperidyl formaldehgde (III) 22.4g (0.11mol), [Et is added successively in there-necked flask 3nH] Cl-AlCl 3(2:3, by AlCl 3count 0.3mol), control temperature 55 ~ 60 DEG C is also held time 5 hours, be warmed up to 165 ~ 175 DEG C and maintain reaction 6 hours, TLC monitors reaction end, after reaction terminates, be down to room temperature, product and ionic liquid AUTOMATIC ZONING, product layer is poured in 5% hydrochloric acid frozen water, and suction filtration obtains crude product, by re-crystallizing in ethyl acetate, obtain 1-benzyl-4-(5,6 dimethoxy-1-indone-2-methylene radical)-piperidines (IV) 33.6g, yield 89%, purity 99.7%, ionic liquid layer dewater Posterior circle use.
Embodiment 4
The preparation of E 2020 (I)
By 25.8g (0.068mol) compound 1-benzyl-4-(5,6 dimethoxy-1-indone-2-methylene radical)-piperidines (IV) is dissolved in 150ml Virahol, add 2.5g10% palladium charcoal again, mixture reacts 4 hours under normal pressure, temperature 40 DEG C of conditions, Filtration of catalyst, boil off solvent again, the ethyl acetate solution of 10% hydrochloric acid is added in resistates, stirring heating dissolves rear evaporated under reduced pressure, residuum alcohol-ether (2:1) recrystallization obtains E 2020 (I) 25.5g, yield 90%, purity 99.8%.
Embodiment 5
The preparation of E 2020 (I)
By 25.8g (0.068mol) compound 1-benzyl-4-(5,6 dimethoxy-1-indone-2-methylene radical)-piperidines (IV) is dissolved in 150ml Virahol, add 2.5g10% palladium charcoal again, mixture reacts 4 hours under normal pressure, temperature 60 C condition, Filtration of catalyst, boil off solvent again, the ethyl acetate solution of 10% hydrochloric acid is added in resistates, stirring heating dissolves rear evaporated under reduced pressure, residuum alcohol-ether (2:1) recrystallization obtains E 2020 (I) 22.3g, yield 87%, purity 99.8%.
Embodiment 6
The preparation of E 2020 (I)
By 25.8g (0.068mol) compound 1-benzyl-4-(5,6 dimethoxy-1-indone-2-methylene radical)-piperidines (IV) is dissolved in 150ml formic acid, add 2.5g10% palladium charcoal again, mixture reacts 4 hours under normal pressure, temperature 40 DEG C of conditions, Filtration of catalyst, boil off solvent again, the ethyl acetate solution of 10% hydrochloric acid is added in resistates, stirring heating dissolves rear evaporated under reduced pressure, residuum alcohol-ether (2:1) recrystallization obtains E 2020 (I) 25.2g, yield 89%, purity 99.9%.

Claims (7)

1. a preparation method for E 2020, is characterized in that, described preparation method comprises the steps:
A, compound ii and compound III are reacted under Lewis acidic ionic liquid catalysts conditions, and one kettle way obtains compounds Ⅳ;
B, compounds Ⅳ obtain chemical compounds I through reduction, salify;
Synthetic route is as follows:
2. the preparation method of E 2020 according to claim 1, is characterized in that: described in step a, Lewis acidic ionic liquid catalyzer is obtained by reacting by quaternary amine and Lewis acid.
3. the preparation method of E 2020 according to claim 2, is characterized in that: described quaternary amine is triethylamine hydrochloride, chlorination N-alkyl pyridine or chlorination 1,3-dialkylimidazolium.
4. the preparation method of E 2020 according to claim 2, is characterized in that: described Lewis acid is aluminum trichloride (anhydrous), FERRIC CHLORIDE ANHYDROUS or Zinc Chloride Anhydrous.
5. the preparation method of E 2020 according to claim 2; it is characterized in that; Lewis acidic ionic liquid catalyst synthesis step is: under nitrogen protection, by quaternary amine and Lewis acid according to mol ratio 1:1 ~ 1:6 batch mixing, obtains Lewis acidic ionic liquid.
6. according to the preparation method of the E 2020 described in claim 1, it is characterized in that: in step a compound ii, compound III and ionic liquid, between Lewis acid, mol ratio is 1:1 ~ 1.1:2 ~ 3.
7. according to the preparation method of the E 2020 described in claim 1, it is characterized in that: step a concrete steps are: compound ii and compound III are under Lewis acidic ionic liquid catalysts conditions, control temperature of reaction 40 ~ 60 DEG C and hold time 4 ~ 5 hours, Aldol condensation reaction occurs; Be warmed up to 145 ~ 175 DEG C and maintain reaction 5 ~ 6 hours, occurring to pay gram alkylated reaction.
CN201511030894.XA 2015-12-31 2015-12-31 A kind of preparation method of Doneppezil Hydrochloride Active CN105418488B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201511030894.XA CN105418488B (en) 2015-12-31 2015-12-31 A kind of preparation method of Doneppezil Hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201511030894.XA CN105418488B (en) 2015-12-31 2015-12-31 A kind of preparation method of Doneppezil Hydrochloride

Publications (2)

Publication Number Publication Date
CN105418488A true CN105418488A (en) 2016-03-23
CN105418488B CN105418488B (en) 2017-09-29

Family

ID=55497094

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201511030894.XA Active CN105418488B (en) 2015-12-31 2015-12-31 A kind of preparation method of Doneppezil Hydrochloride

Country Status (1)

Country Link
CN (1) CN105418488B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109354580A (en) * 2018-11-21 2019-02-19 山东罗欣药业集团股份有限公司 A kind of preparation method of Doneppezil Hydrochloride
CN111100062A (en) * 2019-12-30 2020-05-05 山东罗欣药业集团恒欣药业有限公司 Synthesis method of donepezil hydrochloride

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070191610A1 (en) * 2006-02-16 2007-08-16 Mahesh Nagarimadugu Process for the preparation of donepezil hydrochloride
WO2007108011A2 (en) * 2006-03-20 2007-09-27 Ind-Swift Laboratories Limited Process for the preparation of highly pure donepezil
CN101671366A (en) * 2008-09-09 2010-03-17 王忠卫 Environmentally-friendly synthesis method for phenylphosphonic dichloride
CN102942591A (en) * 2012-11-21 2013-02-27 山东科技大学 Method for synthesizing diphenyl phosphonium chloride
CN103480412A (en) * 2013-08-13 2014-01-01 滨海雅克化工有限公司 Ionic liquid catalyst used in preparation of bisphenol A (phenyl polyphosphate) and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070191610A1 (en) * 2006-02-16 2007-08-16 Mahesh Nagarimadugu Process for the preparation of donepezil hydrochloride
WO2007108011A2 (en) * 2006-03-20 2007-09-27 Ind-Swift Laboratories Limited Process for the preparation of highly pure donepezil
CN101671366A (en) * 2008-09-09 2010-03-17 王忠卫 Environmentally-friendly synthesis method for phenylphosphonic dichloride
CN102942591A (en) * 2012-11-21 2013-02-27 山东科技大学 Method for synthesizing diphenyl phosphonium chloride
CN103480412A (en) * 2013-08-13 2014-01-01 滨海雅克化工有限公司 Ionic liquid catalyst used in preparation of bisphenol A (phenyl polyphosphate) and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
韩波: "多奈哌齐的新型合成路线研究", 《四川大学硕士学位论文》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109354580A (en) * 2018-11-21 2019-02-19 山东罗欣药业集团股份有限公司 A kind of preparation method of Doneppezil Hydrochloride
CN109354580B (en) * 2018-11-21 2020-08-07 山东罗欣药业集团股份有限公司 Preparation method of donepezil hydrochloride
CN111100062A (en) * 2019-12-30 2020-05-05 山东罗欣药业集团恒欣药业有限公司 Synthesis method of donepezil hydrochloride

Also Published As

Publication number Publication date
CN105418488B (en) 2017-09-29

Similar Documents

Publication Publication Date Title
JP2004507518A (en) Process for producing N-aryl-anthranilic acid and its derivatives
CN101891649A (en) Novel 3-cyano methyl benzoate preparing method
CN103664788B (en) Prepare the method for dexmedetomidine
CN105418488A (en) Preparation method of donepezil hydrochloride
WO2015078235A1 (en) Method for preparing medetomidine intermediate
JP6030752B2 (en) Method for producing oxetane-3-ylmethanamine
CN105254611B (en) The preparation method of the carboxylic acid of benzothiophene 2
JP2002275132A (en) Method for producing high purity quaternary ammonium inorganic acid salt
CN111320571B (en) Method for preparing 4-dimethylaminopyridine
CN109503477B (en) Triarylmethane compound and high-efficiency catalytic synthesis method thereof
WO2022126942A1 (en) Synthesis method for cyclopropyl-containing chiral amine hydrochloride
CN108084093B (en) Method for synthesizing 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid by one-pot method
CN101723889B (en) Method for synthesizing 6-chloropyridine-3-carbonyl chloride
US20180009744A1 (en) Processes for the preparation of compounds, such as 3-arylbutanals, useful in the synthesis of medetomidine
CN101516845A (en) Process for the preparation of 2,5-bis-(2,2,2-trifluoroethoxy)-n-(2-piperidylmethyl)-benzamide and salts thereof
CN106748725B (en) preparation method of 4-chloro-2-fluoro-phenylpropionic acid
CN109810052B (en) Simple and convenient preparation method of high-selectivity apatinib
CN102766077B (en) Novel method for preparing 1-phenyl-2-benzene sulfonyl acetophenone
CN105017232A (en) Synthesis method of triazole bactericide
CN103755657A (en) Preparation method of rivaroxaban intermediate
CN104672180A (en) Chiral preparation method of [(1S)-3-methyl-1-[[(2R)-2-methylepoxyethyl]carbonyl]butyl]tert-butyl carbamate
CN104045608B (en) A kind of substituted piperazine like compound and prepare the method for vilazodone intermediate
CN107652195A (en) A kind of preparation method of 1 amino cyclopropanecarboxylic acid
CN101837303A (en) Novel nickel catalyst and preparation method and application thereof
JP4587139B2 (en) A method for producing an aminoalkoxycarbostyril derivative.

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant